Kyverna Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Kyverna Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2023 to Q4 2024.
  • Kyverna Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending December 31, 2024 was $4.16M, a 20.6% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $4.16M -$1.08M -20.6% Dec 31, 2024 10-K 2025-03-27
Q3 2024 $4.97M Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $5.72M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $6.46M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.24M Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.